Publications by authors named "Greg Cadelina"

Claim this Profile
C
Correction to "PROTACs Targeting BRM (SMARCA2) Afford Selective Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models".
Michael Berlin, Jennifer Cantley, Mark Bookbinder, Elizabeth Bortolon, Fabio Broccatelli, Greg Cadelina

J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROTACs Targeting BRM (SMARCA2) Afford Selective Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models.
Michael Berlin, Jennifer Cantley, Mark Bookbinder, Elizabeth Bortolon, Fabio Broccatelli, Greg Cadelina

J Med Chem· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies.
Amy Easton, Marianne L Jensen, Congwei Wang, Peter H Hagedorn, Yuwen Li, Greg Cadelina

Mol Ther Nucleic Acids· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's disease.
Paul D Wes, Amy Easton, John Corradi, Donna M Barten, Nino Devidze, Greg W Cadelina

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis